Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 4, Number 1—March 1998

Synopsis

Proteases of Malaria Parasites: New Targets for Chemotherapy

Philip J. RosenthalComments to Author 
Author affiliation: San Francisco General Hospital and University of California, San Francisco, California, USA

Main Article

Figure

Protease targets in erythrocytic malaria parasites. The Plasmodium falciparum erythrocytic life cycle is shown schematically, and data supporting cysteine (CP), serine (SP), and aspartic (AP) proteases of the different parasite stages as chemotherapeutic targets are provided in italics.

Figure. Protease targets in erythrocytic malaria parasites. The Plasmodium falciparum erythrocytic life cycle is shown schematically, and data supporting cysteine (CP), serine (SP), and aspartic (AP) proteases of the different parasite stages as chemotherapeutic targets are provided in italics.

Main Article

Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external